Related Experiment Video
Updated: Apr 11, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Desonide foam: a review
Daniel Parish1, Noah Scheinfeld
1Pennsylvania Hospital, University of Pennsylvania, Philadelphia, PA, USA.
Abstract:
Desonide foam is a newly approved topical corticosteroid preparation of 0.05% desonide. It has been shown effective compared with vehicle placebo in the treatment of mild-to-moderate atopic dermatitis in both pediatric and adult populations. Given the favorable safety profile of all other desonide preparations and their utility as a low potency corticosteroid, desonide foam promises to be a useful addition to the armamentarium, when other desonide vehicles might be less acceptable.
Related Concept Videos
PPE Use in Healthcare Settings II: Doffing
Clinical Applications of Epidermal Stem Cells
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids

